Evidence map›Paper›PMID 32100173›Full record

ArticleEuropean journal of epidemiology2020

Lifelines NEXT: a prospective birth cohort adding the next generation to the three-generation Lifelines cohort study.

Willemijn D B Warmink-Perdijk, Lilian L Peters, Ettje F Tigchelaar, Jackie A M Dekens, Soesma A Jankipersadsing, Alexandra Zhernakova, Willem J R Bossers, Jan Sikkema, Ank de Jonge, Sijmen A Reijneveld and 5 more

Open access · hybridAbstract read
In one paragraph

Article in European journal of epidemiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 35 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Examining the healthy human microbiome concept.Nature reviews. Microbiology · 2025
    Review
  10. Maternal Nutrition, Toxicants, and Epigenetic Programming of Obesity Across Generations.Diabetes, metabolic syndrome and obesity : targets and therapy · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Willemijn D B Warmink-PerdijkDepartment of Midwifery Science, Amsterdam Public Health Research Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, Van de Boechorstraat 7, 1081 BT, Amsterdam, The Netherlands. w.d.b.warmink@umcg.nl.ORCID http://orcid.org/0000-0003-1223-4923
Lilian L PetersDepartment of Midwifery Science, Amsterdam Public Health Research Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, Van de Boechorstraat 7, 1081 BT, Amsterdam, The Netherlands.
Ettje F TigchelaarDepartment of Genetics, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands.
Jackie A M DekensDepartment of Genetics, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands.
Soesma A JankipersadsingDepartment of Genetics, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands.
Alexandra ZhernakovaDepartment of Genetics, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands.
Willem J R BossersLifelines Cohort Study, Bloemsingel 1, 9713 BZ, Groningen, The Netherlands.
Jan SikkemaCenter for Development and Innovation, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands.
Ank de JongeDepartment of Midwifery Science, Amsterdam Public Health Research Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, Van de Boechorstraat 7, 1081 BT, Amsterdam, The Netherlands.
Sijmen A ReijneveldDepartment of Health Sciences, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands.
Henkjan J VerkadeDepartment of Pediatrics, Pediatric Gastroenterology - Hepatology, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands.
Gerard H KoppelmanDepartment of Pediatric Pulmonology and Pediatric Allergy, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands.
Cisca WijmengaDepartment of Genetics, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands.
Folkert KuipersDepartment of Pediatrics/Laboratory Medicine, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands.
Sicco A ScherjonDepartment of Obstetrics and Gynecology, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands.
University Medical Center Groningen · NLAcademie Verloskunde Amsterdam Groningen · NL

Funding

European Research Council ERC starting Grand ERC- 715772Netherlands Organisation for Scientific Research (NWO) VIDI grand 016.178.056
6 · The paper itself

Abstract

Epidemiological research has shown there to be a strong relationship between preconceptional, prenatal, birth and early-life factors and lifelong health. The Lifelines NEXT is a birth cohort designed to study the effects of intrinsic and extrinsic determinants on health and disease in a four-generation design. It is embedded within the Lifelines cohort study, a prospective three-generation population-based cohort study recording the health and health-related aspects of 167,729 individuals living in Northern Netherlands. In Lifelines NEXT we aim to include 1500 pregnant Lifelines participants and intensively follow them, their partners and their children until at least 1 year after birth. Longer-term follow-up of physical and psychological health will then be embedded following Lifelines procedures. During the Lifelines NEXT study period biomaterials-including maternal and neonatal (cord) blood, placental tissue, feces, breast milk, nasal swabs and urine-will be collected from the mother and child at 10 time points. We will also collect data on medical, social, lifestyle and environmental factors via questionnaires at 14 different time points and continuous data via connected devices. The extensive collection of different (bio)materials from mother and child during pregnancy and afterwards will provide the means to relate environmental factors including maternal and neonatal microbiome composition) to (epi)genetics, health and developmental outcomes. The nesting of the study within Lifelines enables us to include preconceptional transgenerational data and can be used to identify other extended families within the cohort.

Indexed as

AgingBiological Specimen BanksMothersPopulation SurveillanceAdolescentAdultAgedAged, 80 and overChildChild, PreschoolCohort StudiesFemaleFetal BloodHumansInfantLife StyleBiobankBirth cohortDevelopmental Origins of Health and Disease (DOHaD)MicrobiomeProspective studyTransgenerational effects

Identifiers

PMID32100173
PMCPMC7125065
OpenAlexW3007395212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.